Babatunde, O., Schwartz, G. K., Keohan, M. L., D'Angelo, S. P., Gounder, M. M., Chi, P., Antonescu, C. R., Landa, J., Seier, K., Qin, L., Crago, A. M., Singer, S., Tap, W. D., Dickson, M. A. (2025). Overall survival from the open label phase 2 trial of palbociclib in patients with advanced well differentiated/dedifferentiated liposarcoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11552